cto vs medical management
TRANSCRIPT
![Page 1: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/1.jpg)
Dr. Pavankumar P RasalkarSenior resident
Dept of CardiologyPGIMER, Chandigarh
![Page 2: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/2.jpg)
INTRODUCTION• Studies have reported the benefits of
revascularization: PCI and CABG in pts with coronary chronic total occlusion (CTO)
• CABG , widely performed in pts with multiple CTOs, multivessel CAD, or diabetes
• The surgical outcomes in pts with CTOs have improved
• Due to better perioperative management and increased surgical experience
![Page 3: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/3.jpg)
• Success rate of PCI in pts with CTO has increased due to improvements in device technology: drug-eluting stents, dedicated guidewires, and microcatheters
• A high frequency of failed PCI, perioperative mortality, and potentially lethal complications is seen in pts with CTO
• Clinicians are more likely to treat pts with CTO and abundant distal collateral flow with medical therapy alone
![Page 4: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/4.jpg)
• No studies have compared the long-term clinical outcomes of
pts with CTO and well-developed collateral circulation who
undergo medical therapy versus those who undergo
revascularization
• This study aimed to compare the long-term survival
outcomes a/w revascularization versus medical therapy in pts
with at least 1 CTO and well-developed collateral circulation
![Page 5: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/5.jpg)
METHODS
Between March 2003 and February 2012, 2,024 consecutive patients were enrolled in the retrospective Samsung Medical Center CTO registry.
Inclusion Criteria:1. At least 1 CTO detected on diagnostic coronary angiography; 2. Symptomatic angina and/or a positive functional ischemia study
![Page 6: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/6.jpg)
Exclusion criteria: 1) Previous CABG; 2) History of cardiogenic shock or CPR3) ST-segment elevation AMI during the last 48 h
• Out of 2,024 pts included in the registry, 738 pts had Rentrop grade 3 collateral flow and were included in the final analysis
• Revascularization of CTOs was accomplished by CABG or PCI with drug-eluting stent based on the pt’s and physician’s preference
![Page 7: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/7.jpg)
• Primary outcome was cardiac death during follow-up• Secondary outcomes were all-cause death, MI,
repeat revascularization, and major adverse cardiac event (MACE).
STATISTICAL ANALYSIS: • Continuous variables were compared using the
Student t test or the Wilcoxon rank-sum test• Categorical data was tested using the Fisher exact
test or the chi-square test as appropriate. • Cumulative event rates were estimated by the
Kaplan-Meier method
![Page 8: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/8.jpg)
![Page 9: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/9.jpg)
![Page 10: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/10.jpg)
![Page 11: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/11.jpg)
![Page 12: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/12.jpg)
![Page 13: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/13.jpg)
![Page 14: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/14.jpg)
Discussion
• Several studies have shown a survival benefit in patients with CTO who undergo successful PCI compared with those who undergo failed procedures, suggesting that survival depends on procedural success
• However, these results are limited in their application, as it is difficult to predict the success of an intervention
![Page 15: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/15.jpg)
• In contrast this study evaluated the clinical outcomes of overall treatment strategies (including medical therapy, CABG, successful PCI, or failed PCI, and so on) using an intent-to-treat analysis of a large, dedicated registry
• Results would be helpful when making a clinical decision in real-world practice.
![Page 16: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/16.jpg)
PERSISTENT MYOCARDIAL ISCHEMIA DESPITE ABUNDANT COLLATERAL CIRCULATION
• Hansen reported that distal collateralization led to greatly improved survival and freedom from MI in patients with ischemic heart disease
• Many clinicians recommend medical therapy alone in order to avoid procedural complications
![Page 17: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/17.jpg)
• Studies have reported a weak relationship between visualized collaterals and cardiac events
• ?Coronary steal
• Well developed collateral circulation may not protect the myocardium
• This study supported this finding
![Page 18: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/18.jpg)
LIMITATIONS
• Nonrandomized, retrospective, observational study
• Retrospective nature : could not identify the alteration
of medical therapy in study patients during follow-up
• Rentrop classification : reflects collaterals visualized by
angiography and may not reflect their functional
capabilities or physiologic consequences
![Page 19: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/19.jpg)
• A high prevalence of multivessel disease, may not be
generalized to populations with less severe disease
• Did not routinely evaluate the amount of viable
myocardium or ischemia of study patients using
functional ischemia testing
![Page 20: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/20.jpg)
CONCLUSIONS
• Patients with CTO and well-developed collateral circulation, revascularization with medical therapy significantly decreased the long-term risk of cardiac death, all-cause death, and MACE compared with treatment with medical therapy alone
• Revascularization may be recommended as an initial treatment
• A large scale randomized trial is needed to confirm these findings
![Page 21: CTO vs Medical management](https://reader035.vdocument.in/reader035/viewer/2022062903/58ecddd81a28abec2f8b46af/html5/thumbnails/21.jpg)
THANK YOU